Author:
Markman Maurie,Hakes Thomas,Reichman Bonnie,Curtin John,Barakat Richard,Rubin Stephen,Jones Walter,Lewis John L.,Almadrones Lois,Hoskins William
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference23 articles.
1. Barlow JJ, Lele SB (1986) Etoposide (VP-16) plus cisplatin (DDP): a new active chemotherapeutic combination in patients with stage III-IV ovarian adenocarcinoma. J Surg Oncol 32: 43–45
2. De Lena M, Lorusso V, Romito S (1986) Cisplatin plus etoposide as second-line treatment in advanced ovarian cancer. Cancer Treat Rep 70: 893–895
3. Dombernowsky P, Nissen JI (1973) Schedule dependency of the antileukemic activity of the podophyllotoxin derivative VP 16-213 (NSC 141540) in L 1210 leukemia. Acta Path Microbiol Scand [A] 81: 715–724
4. Dottino PR, Goodman HM, Kredentser D (1987) Clinical trial of etoposide and cisplatin as salvage therapy in advanced ovarian carcinoma. Gynecol Oncol 27: 350–356
5. Edmonson JH, Decker DG, Malkasian GD, Webb MJ, Jorgenson EO (1978) Phase II evaluation of VP-16-213 (NSC-141540) in patients with advanced ovarian carcinoma resistant to alkylating agents. Gynecol Oncol 6: 7–9
Cited by
52 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献